Skip to content

Prognostic Outcomes of Different Drug Delivery Methods in Sudden deafness

Novel Drug Delivery Methods and Prognostic Factors in Sudden Sensorineural Hearing Loss

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500112070
Enrollment
Unknown
Registered
2025-11-10
Start date
2025-11-17
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sudden sensorineural hearing loss (SSNHL)

Interventions

Ntrathecal Administration Group:None
Intranasal Delivery Group:None
Corticosteroid Administration Route:None

Sponsors

Shandong Second Provincial General Hospital, Shandong Provincial ENT Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Aged between 18 and 70 years; 2.Meeting diagnostic criteria for sudden sensorineural hearing loss; 3.Symptom duration not exceeding 7 days; 4.Availability of comprehensive datasets including hematological profiles, audiological examinations, vestibular function tests, and inner ear MRI imaging.

Exclusion criteria

Exclusion criteria: 1.Congenital or Fluctuant Hearing Loss; 2.Ménière's disease;Middle ear malformations; 3.History of otitis media or middle ear surgery; 4.Genetic or traumatic hearing loss; 5.History of head trauma; 6.Cerebellopontine angle occupying lesions; 7.Previous history of hearing impairment; 8.History of ototoxic drug use; 9.Contraindications to corticosteroid therapy.

Design outcomes

Primary

MeasureTime frame
Hearing level;

Secondary

MeasureTime frame
Speech Recognition Score (SRS);Tinnitus;Vertigo;

Countries

China

Contacts

Public ContactWang Mingming

Shandong Second Provincial General Hospital,(Shandong ENT Hospital, Shandong Institute of Otolaryngology)

wmmship@126.com+86 531 83086678

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026